The US biotechnology company Novavoxin’s Kovovax vaccine is said to be 90 percent effective. The company also claims that it is 100 percent effective in protecting against corona.
Kovacin and Covshield vaccines are available in India. They are made in India and delivered to the people. However, due to the shortage of the vaccine, the Central Government has allowed the serum company to manufacture the vaccine in India from foreign companies.
Following this, a test for the Kovovax vaccine from the US company Nova Vox is underway in India. The vaccine is likely to be available in the markets in September this year.
It also explains how the Kovovox vaccine differs from other vaccines. The Kovovax vaccine is prepared by the charity Spike Protein. It looks like a corona virus.
This protein in the vaccine enhances immunity by fighting hard against a limited virus such as the corona virus. Among the mutated viruses alpha and beta, this virus has completed 3 experiments at once.
It is 90 percent effective against corona virus. It protects us 100 percent from the corona virus. It will be available in India soon.
Facebook Comments Box
